Philip Morris International Inc. Quarterly Report for Q3 Ended Sep 30, 2014

Summary

Philip Morris International Inc. (PM) reported its third-quarter 2014 financial results, showcasing a mixed performance impacted by significant asset impairment and exit costs. For the nine months ended September 30, 2014, net revenues saw a modest increase of 0.9% to $60.2 billion, driven by price increases and favorable currency movements in certain regions, though this was partially offset by unfavorable volume/mix and significant currency headwinds. However, operating income experienced a substantial decline of 11.2% to $9.2 billion. This was primarily attributed to unfavorable currency impacts, a decrease in volume/mix, substantial asset impairment and exit costs related to factory closures in the Netherlands, Australia, and Canada, higher manufacturing costs, and increased marketing, administration, and research expenses. Diluted earnings per share (EPS) for the nine months decreased by 7.2% to $3.73. The company revised its full-year 2014 diluted EPS forecast downwards, reflecting these challenges and anticipated currency pressures.

Key Highlights

• 1Net revenues for the nine months ended September 30, 2014, increased by 0.9% to $60.2 billion, while for the three months ended September 30, 2014, they increased by 3.4% to $21.3 billion.
• 2Operating income for the nine months decreased by 11.2% to $9.2 billion, and for the three months, it decreased by 7.1% to $3.3 billion, largely due to unfavorable currency impacts and higher costs.
• 3Significant asset impairment and exit costs of $503 million pre-tax were recorded in the nine months ended September 30, 2014, primarily related to factory closures in the Netherlands, Australia, and Canada, impacting profitability.
• 4Diluted EPS for the nine months decreased by 7.2% to $3.73, and for the three months, it decreased by 4.2% to $1.38, reflecting the challenges in operating income.
• 5The company revised its full-year 2014 reported diluted EPS forecast to a range of $4.76 to $4.81, a reduction from previous expectations and a decrease from $5.26 in 2013.
• 6Despite overall declines, PM International saw price increases contributing positively to net revenues in most segments, and market share gains in several key markets.
• 7The company continues to invest in Reduced-Risk Products (RRPs), with plans for commercialization and further scientific studies, signaling a strategic shift towards innovation.

Frequently Asked Questions